Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC. - Wikidata - wikimedia - TriplyDB

Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC.

Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC.

http://www.wikidata.org/entity/Q32066792

about

In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase HIV-1 reverse transcriptase inhibitors.

P2860

Q33857855-A7FF4E82-5510-4BC5-BA30-3C977C61AA08 Q36763644-CB311633-FFF7-4DE9-A8D0-268577DF8653

P2860

Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC.

http://www.wikidata.org/entity/Q32066792

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@ast

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@en

type

label

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@ast

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@en

prefLabel

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@ast

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@en

P1433

Q32066792-0D1BB225-EB1A-49E2-B57E-D439E40EEE85

P1476

Q32066792-8871386B-798E-442B-9F8F-B95F2555252B

P2093

Q32066792-0193BD85-BE03-4210-816D-BE7CC3E68302

Q32066792-084341D8-7D39-49C7-B40C-C7409F1E8D29

Q32066792-4AA517F7-7919-447B-B003-FE159E815E49

Q32066792-8676353F-4B44-4DDD-BDE6-101842A0E1CE

Q32066792-B2F54A70-93A0-4582-AB3A-BE4CA9A18E2E

Q32066792-E28E7577-DB79-462B-A23D-CDC1155B510B

Q32066792-F1E19DC8-FCAC-4AED-9355-DB48EF4ABCE3

P2860

Q32066792-1F5DF8BC-8DC2-41A1-B936-5FD23FC5D7D5

Q32066792-249CEB07-5412-4AC4-9DB3-4924CE3347F1

Q32066792-2F1E82FF-CC89-4C21-B659-2D5E8123802D

Q32066792-392E9504-8E80-49A3-AE35-B58DFD526E4C

Q32066792-393D9FE6-4E80-45B5-9695-CDE07AB21199

Q32066792-3CE1714A-3F6A-46E6-869D-1E8BF7457EB8

Q32066792-4657D9C1-E68D-4705-8542-C0DB4D055DE1

Q32066792-48927330-C8F6-4BF8-9613-69F8135BF96B

Q32066792-5BC7C364-8C04-467E-9426-84AEA7627393

Q32066792-7C746EF3-DDB0-4D22-AEAF-B1AE7E8FA9DE

P304

Q32066792-F0F55F14-CC6A-47B4-93D8-CFF14E144F5F

P31

Q32066792-D0F76F43-ECE7-4365-8AD9-8CD7813F2177

P356

Q32066792-791EA36D-9AF3-4F29-8ACC-C0B6A7A76D6E

P433

Q32066792-AED52502-4351-4DEB-8A19-F8F8EB9361BF

P478

Q32066792-C66A05C3-6561-4382-B770-CC25D91174C9

P577

Q32066792-79FD4F46-5AE8-4FDF-8EB1-CC1E112DE58A

P5875

Q32066792-1EBE2030-20B1-4EBE-8B46-DED57B96FF16

P698

Q32066792-E40484F3-C91A-4622-B913-152863F0E049

P356

095632020001100602

P1433

Antiviral Chemistry & Chemotherapy

P1476

Selection of resistance-confer ...... tors (+/-)dOTC and (+/-)dOTFC.

@en

P2093

H Salomon

http://www.w3.org/2001/XMLSchema#string

M A Wainberg

http://www.w3.org/2001/XMLSchema#string

M Oliveira

http://www.w3.org/2001/XMLSchema#string

N Richard

http://www.w3.org/2001/XMLSchema#string

R Rando

http://www.w3.org/2001/XMLSchema#string

T Mansour

http://www.w3.org/2001/XMLSchema#string

Z Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids

Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase

Mutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugs

P304

359-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/095632020001100602

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12103575

http://www.w3.org/2001/XMLSchema#string

P698

11227993

http://www.w3.org/2001/XMLSchema#string